"The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-ap"...
- Clinician Information:
Zoladex 3.6 Patient Information including If I Miss a Dose
In this Article
- What is goserelin (Zoladex 3.6)?
- What are the possible side effects of goserelin (Zoladex 3.6)?
- What is the most important information I should know about goserelin (Zoladex 3.6)?
- What should I discuss with my healthcare provider before receiving goserelin (Zoladex 3.6)?
- How is goserelin given (Zoladex 3.6)?
- What happens if I miss a dose (Zoladex 3.6)?
- What happens if I overdose (Zoladex 3.6)?
- What should I avoid while receiving goserelin (Zoladex 3.6)?
- What other drugs will affect goserelin (Zoladex 3.6)?
- Where can I get more information?
What happens if I miss a dose (Zoladex 3.6)?
Call your doctor for instructions if you miss an appointment for your goserelin injection.
What happens if I overdose (Zoladex 3.6)?
Since the goserelin implant contains a specific amount of the medication, you are not likely to receive an overdose.
What should I avoid while receiving goserelin (Zoladex 3.6)?
Avoid drinking alcohol. It can increase your risk of bone loss while you are being treated with goserelin.
Avoid smoking, which can increase your risk of bone loss, stroke, or heart problems.
What other drugs will affect goserelin (Zoladex 3.6)?
There may be other drugs that can interact with goserelin. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Where can I get more information?
Your doctor or pharmacist can provide more information about goserelin.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 5.02. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Zoladex 3.6 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find support and advances in treatment.